|

Literature Selection / Selezione
della Letteratura
-
Mustacchi G et al.: "Breast cancer in elderly women: a different
reality? Results from the NORA study",
Ann Oncol. 2007 Jun;18(6):991-6
-
Ganjoo K et al.: "Non-Hodgkin lymphoma of the breast",
Cancer. 2007 Jul 1;110(1):25-30
-
Graf O et al.: "Probably Benign Breast Masses at US: Is
Follow-up an Acceptable Alternative to Biopsy?",
Radiology. 2007 Jul;244(1):87-93
-
Pediconi F et al.: "Contrast-enhanced MR mammography for
evaluation of the contralateral breast in patients with
diagnosed unilateral breast cancer or high-risk lesions",
Radiology. 2007 Jun;243(3):670-80
-
Travaini LL et al.: "Neoadjuvant therapy in locally advanced
breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable
technique to predict therapy response",
Breast. 2007
Jun;16(3):262-70
-
Freedman GM et al.: "Four-week course of radiation for breast
cancer using hypofractionated intensity modulated radiation
therapy with an incorporated boost",
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):347-53
-
Deutsch M et al.: "An association between postoperative
radiotherapy for primary breast cancer in 11 National Surgical
Adjuvant Breast and Bowel Project (NSABP) studies and the
subsequent appearance of pleural mesothelioma",
Am J Clin
Oncol. 2007 Jun;30(3):294-6
-
Formenti SC et al.: "Phase I-II trial of prone accelerated
intensity modulated radiation therapy to the breast to optimally
spare normal tissue",
J Clin Oncol. 2007 Jun 1 ;25(16):2236-42
-
Akyurek S et al.: "Stereotactic radiosurgical treatment of
cerebral metastases arising from breast cancer",
Am J Clin
Oncol. 2007 Jun;30(3):310-4
-
Veronesi G et al.: "Results of chest wall resection for
recurrent or locally advanced breast malignancies",
Breast. 2007
Jun;16(3):297-302
-
Pierce JP et al.: "Greater Survival After Breast Cancer in
Physically Active Women With High Vegetable-Fruit Intake
Regardless of Obesity", J Clin Oncol. 2007, Jun
10;25(17):2345-2351
-
Titeca G et al.: "Impact of cosmetic care on quality of life in
breast cancer patients during chemotherapy and radiotherapy: an
initial randomized controlled study",
J Eur Acad Dermatol Venereol. 2007 Jul;21(6):771-6
-
Potter S et al.: "Patient satisfaction and time-saving
implications of a nurse-led nipple and areola reconstitution
service following breast reconstruction",
Breast. 2007
Jun;16(3):293-6
Editorial /
Editoriale
-
"Long-term follow-up of early-stage breast cancer patients
treated by breast-conserving surgery should be based on
mammography" -
David Montgomery,
University Department of Surgery, Glasgow Royal Infirmary,
Glasgow, Scotland, UK
"The recommendations for follow
up after breast cancer are inconsistent from country to country,
largely as a result of inadequate evidence on which to base
recommendations. Our data highlight a number of important issues.
Among 1312 women treated with breast conserving surgery for
early stage breast cancer and followed for a median of ten years,
potentially treatable relapse after occured at a constant rate
of 1 - 1.5% for at least ten years with no early peak in
incidence. If routine follow up is to be provided after breast
cancer, then it must continue for at least ten years in some
form. However, clinical examination detected only 13% of
potentially treatable relapses, as compared with 51%
mammographically and 35% patient detected. Moreover,
ipsilateral breast relapse detected by clinical examination is
associated with a significantly poorer survival than such
relapse detected by mammography or patient self-examination. It
may be then that routine clinical examination is unnecessary. In
contrast, mammography is of central importance to the detection
of treatable relapse. The yield when undertaken annually is
5.37 relapses detected for every 1000 mammograms performed, at
least equivalent to the yield seen under a three yearly protocol
in the general screening population in the UK. This justifies
the use of annual mammography in this patient population. Given
the rising incidence of new contralateral cancers seen after ten
years in several studies, there may be justification for
continuing to provide annual mammography indefinitely. As
routine clinic visits are poor at addressing the other aims of
follow up, it may be more appropriate to ensure that a good
educational and self awareness programme is in place with easy
access to specialist care for patients with problems. Ideally,
a remote screening tool to assess psychological well being and
adverse effects of treatment would be introduced which would
allow those who have problems to be detected and brought back to
clinic. Much less frequent clinic visits could be planned to
coincide with changes in adjuvant hormone therapy. This more
focussed approach would benefit the patient and be more cost
effective". (Comment on paper:
Montgomery DA et al.: "Changing
pattern of the detection of locoregional relapse in breast
cancer: the Edinburgh experience",
Br J Cancer. 2007
Jun 18;96(12):1802-7)
Press Releases / Comunicati
Stampa
-
"Exercise lowers insulin in breast cancer survivors. Study adds
evidence in favor of physical activity" -
Dana-Farber Cancer
Institute, Boston, MA, USA
-
"Study
Finds Dramatic Difference in Survival Rates Among
White and Black Women with Advanced Breast Cancer"
-
University of Texas, M. D. Anderson Cancer Center, Houston, TX,
USA -
"Combined screening approach leads to discovery of gene linked
to breast cancer" -
Dana-Farber Cancer
Institute, Boston, MA, USA
Calendar of Events / Prossimi Eventi Senologici
-
-
First Kuala Lumpur
International Breast and Colorectal Cancer Congress - Aug 9 -11
2007, Kuala Lumpur, Malaysia
-
The 2007 Breast Cancer Symposium, Sep 7 - 8, 2007, San
Francisco, CA, USA -
Joint Meeting of the Slovenian and Austrian Society of Senology,
Sep 13-15, 2007, Graz, Austria

Literature Selection / Selezione della
Letteratura
-
Beesley V et al.: "Lymphedema after gynecological cancer
treatment : prevalence, correlates, and supportive care needs",
Cancer. 2007 Jun 15;109(12):2607-14
-
Lappe JM et al.: "Vitamin D and calcium supplementation reduces
cancer risk: results of a randomized trial",
Am J
Clin Nutr. 2007 Jun;85(6):1586-91
-
Furniss CS et al.: "Human papillomavirus 16 and head and neck
squamous cell carcinoma",
Int J Cancer. 2007 Jun 1;120(11):2386-92
-
Weihkopf T et al.: "Sun exposure and malignant lymphoma: a
population-based case-control study in Germany",
Int J Cancer. 2007 Jun 1;120(11):2445-51
-
Tryggvadottir L et al.: "Prostate Cancer Progression and
Survival in BRCA2 Mutation Carriers", J Natl Cancer Inst,
2007 Jun 12; [Epub ahead of print]
-
D'Amico AV et al.: "Influence of androgen suppression therapy
for prostate cancer on the frequency and timing of fatal
myocardial infarctions",
J Clin Oncol. 2007 Jun 10;25(17):2420-5
-
Spunt SL et al.: "Phase I clinical trial of oxaliplatin in
children and adolescents with refractory solid tumors"J
Clin Oncol. 2007 Jun 1;25(16):2274-80
-
Kyle RA et al.: "Clinical course and prognosis of smoldering
(asymptomatic) multiple myeloma",
N Engl J Med.
2007 Jun 21;356(25):2582-90
-
Khun FR : "Weighing the hazards of erythropoiesis stimulation in
patients with cancer",
N Engl J Med.
2007 Jun 14;356(24):2445-8
-
Longmore GD et al.: "Do cancer cells express functional
erythropoietin receptors?",
N Engl J Med.
2007 Jun 14;356(24):2447
Editorial /
Editoriale
"Can
cancer cells from donors with a yet undetected cancer be
transferred to the transfusion recipient and then develop into a
clinical cancer? Case reports of transmission of cancer by
needle-stick injury or surgical instruments, and the emerging
awareness that viable lineages of donor cells may survive long
term and proliferate in the recipient (michrochimerism), make
this question relevant. Although individuals with a history of
cancer are normally deferred as donors, transfusion with blood
from donors with an undiagnosed incipient cancer is not
uncommon. Our investigation provides no evidence that blood
transfusions from precancerous blood donors are associated with
increased risk of cancer among the recipients. The results
indicate that there is no need for considering screening for
malignant disease among blood donors. This removes yet another
uncertainty regarding possible long-term risks after blood
transfusions"
(Comment on paper:
Edgren G et al.;"Risk of cancer after blood transfusion from
donors with subclinical cancer: a retrospective cohort study",
Lancet. 2007, 19; 369 (9574):
1724-30)
Press Releases / Comunicati
Stampa
-
"Diet may influence survival after treatment for stage III colon
cancer, study suggests" -
Dana-Farber Cancer Institute, Boston, MA, USA
-
"Even when a child with cancer's prognosis is unpromising,
parent/physician communication can provide hope, study finds"
-
Dana-Farber Cancer Institute, Boston, MA, USA -
"FDA Approves New Drug for Advanced Kidney Cancer" -
U.S. Food and Drug Administration
-
"Blood
Test May Help Signal Tumor’s Remission, Return in Throat Cancer
Patients" - National Institutes of Health
(NIH), U. S. Department of Health and Human Services
-
"Shark Cartilage Shows No Benefit as a Therapeutic Agent for
Lung Cancer" -
University of Texas, M. D. Anderson Cancer Center, Houston, TX,
USA
-
"Dasatinib Shows High Early Response Rate as First Treatment for
Chronic
Myelogenous Leukemia" -
University of Texas, M. D. Anderson Cancer
Center, Houston, TX, USA
Clinical Guidelines / Linee guida cliniche (link)
 Literature Selection / Selezione della
Letteratura
Visitate periodicamente le sezioni "Senology News /
Notizie flash in Senologia" e "Oncology
News / Notizie flash in Oncologia" per conoscere in maniera
tempestiva e concisa le novità internazionali in ambito
senologico.ed oncologico
Accedete al Forum di
discussione per eventuali osservazioni, note o commenti
Happy Holidays! / Buone vacanze a tutti!
|